2019年《原发性免疫性血小板减少症的调查和管理:国际共识报告更新》儿童部分解读

摘要近十年来,原发性免疫性血小板减少症(ITP)的诊治和管理进展突飞猛进。基于新证据的不断涌现,2019年新的ITP国际工作组对2010版国际共识报告(ICR)做了更新。新共识针对成人、妊娠期和儿童ITP的诊治管理进行了全面详尽的指导,包括诊断与鉴别诊断、一线治疗、危急重症抢救治疗、二线治疗、生活质量管理及体育活动建议等。该文就共识中儿童ITP相关内容进行重点解读,为临床规范化诊治提供依据。 There have been great progress in the diagnosis,treatment and management of patients with primary immune thrombocytopenia(ITP)in the recent 10 years.based on the new data,the new ITP International Working Group had updated the old International Consensus Report(ICR,Version 2010)in 2019.The 2019 consensus provides recommendations on the diagnosis and differential diagnosis,first-line treatment,emergency treatment for critically ill patients and second-line treatment for ITP in adults,during pregnancy,and in children,as well as life quality management and sporting activities.The article will focus on interpretation of recommendations on ITP for children in the consensus,in order to provide useful information for standardized clinical diagnosis and treatment.

作者徐倩周敏 XU Qian;ZHOU Min(Department of Hematology&Oncology,Chengdu Women’s and Children’s Central Hospital,the Affiliated Women’s and Children’s Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 611731,China)

机构地区电子科技大学医学院附属妇女儿童医院

出处《中国实用儿科杂志》 CSCD 北大核心 2021年第2期86-89,103,共5页 Chinese Journal of Practical Pediatrics

基金成都市科技局科技惠民技术研发项目(2015-HM01-00568-SF)。

关键词疾病管理儿童免疫性血小板减少症解读 disease management child immune thrombocytopenia interpretation

分类号 R72 [医药卫生—儿科]